Skip to main content

Merck & Co., Inc.

corporate_fare Company Profile

Merck & Co., Inc.

MRK·NYSE·Life Sciences·CIK 0000310158

Merck & Co., Inc. is a global healthcare company providing innovative health solutions through prescription medicines, including biologic therapies, vaccines, and animal health products. The company manages its operations primarily on a product basis, with two reportable operating segments: Pharmaceutical and Animal Health. The Pharmaceutical segment encompasses human health pharmaceutical and vaccine products. Human health pharmaceutical products are therapeutic and preventive agents, generally sold by prescription, for treating human disorders. Merck sells these products mainly to drug wholesalers and retailers, hospitals, government agencies, and managed healthcare providers like health maintenance organizations and pharmacy benefit managers. Human health vaccine products include preventive pediatric, adolescent, and adult vaccines, sold primarily to physicians, wholesalers, distributors, and government entities. The Animal Health segment focuses on discovering, developing, manufacturing, and marketing a broad range of veterinary pharmaceutical and vaccine products, alongside health management solutions and services. These offerings aim to prevent, treat, and control diseases in all major livestock and companion animal species. This segment also provides a comprehensive suite of digitally connected identification, traceability, and monitoring products. Merck sells its animal health products to veterinarians, distributors, animal producers, farmers, and pet owners.

Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek monitors MRK SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • FDA Clears Keytruda Combo for Kidney Cancer, Reducing Recurrence Risk by 28%
  • Merck Animal Health to Acquire TARGAN, Expanding Portfolio
  • Keytruda Combination Therapy Cuts Recurrence/Death by 49% in 5-Year Data
  • Merck's Calderasib + Keytruda Combo Gets FDA Breakthrough Designation for KRAS G12C NSCLC
  • Merck Closes $6 Billion Multi-Tranche Debt Offering, Likely Funding Terns Acquisition

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063
Browse all tickers starting with M →
$119.25 +0.20% today
52-week range · as of 2026-05-22 $75.4 – $125.14
Market cap
$294.03B
Volume
10.9M (1.1× avg)
3-mo avg 9.7M
Live data · 2026-06-13 13:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MRK - Latest Insights

MRK
Jun 12, 2026, 5:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $119.17
Real-time Price: $119.25 info
Change: +$0.082 (+0.07%) info
Market Cap: $294.033B info
MRK
Jun 11, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $120.00
Real-time Price: $119.25 info
Change: -$0.748 (-0.62%) info
Market Cap: $294.033B info
MRK
Jun 02, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $115.22
Real-time Price: $119.25 info
Change: +$4.03 (+3%) info
Market Cap: $294.033B info
MRK
May 29, 2026, 7:26 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $120.22
Real-time Price: $119.25 info
Change: -$0.968 (-0.81%) info
Market Cap: $294.033B info
MRK
May 22, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $122.60
Real-time Price: $119.25 info
Change: -$3.35 (-3%) info
Market Cap: $294.033B info
MRK
May 22, 2026, 8:24 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $118.74
Real-time Price: $119.25 info
Change: +$0.512 (+0.43%) info
Market Cap: $294.033B info
MRK
May 21, 2026, 5:00 PM EDT
Source: MFN by Modular Finance
Importance Score:
8
Price at Filing: $115.80
Real-time Price: $119.25 info
Change: +$3.45 (+3%) info
Market Cap: $294.033B info
MRK
May 20, 2026, 4:23 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $113.25
Real-time Price: $119.25 info
Change: +$6.00 (+5%) info
Market Cap: $294.033B info
MRK
May 18, 2026, 6:41 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $112.18
Real-time Price: $119.25 info
Change: +$7.07 (+6%) info
Market Cap: $294.033B info
MRK
May 18, 2026, 6:48 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $111.37
Real-time Price: $119.25 info
Change: +$7.88 (+7%) info
Market Cap: $294.033B info
MRK
May 08, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $111.38
Real-time Price: $119.25 info
Change: +$7.87 (+7%) info
Market Cap: $294.033B info
MRK
May 04, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.11
Real-time Price: $119.25 info
Change: +$6.14 (+5%) info
Market Cap: $294.033B info
MRK
Apr 30, 2026, 6:53 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $119.25 info
Change: +$6.25 (+6%) info
Market Cap: $294.033B info
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $115.00
Real-time Price: $119.25 info
Change: +$4.25 (+4%) info
Market Cap: $294.033B info
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $112.94
Real-time Price: $119.25 info
Change: +$6.31 (+6%) info
Market Cap: $294.033B info
MRK
Apr 24, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $113.99
Real-time Price: $119.25 info
Change: +$5.26 (+5%) info
Market Cap: $294.033B info
MRK
Apr 21, 2026, 11:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $112.55
Real-time Price: $119.25 info
Change: +$6.70 (+6%) info
Market Cap: $294.033B info
MRK
Apr 21, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $116.99
Real-time Price: $119.25 info
Change: +$2.26 (+2%) info
Market Cap: $294.033B info
MRK
Apr 20, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $118.52
Real-time Price: $119.25 info
Change: +$0.732 (+0.62%) info
Market Cap: $294.033B info
MRK
Apr 13, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $119.66
Real-time Price: $119.25 info
Change: -$0.408 (-0.34%) info
Market Cap: $294.033B info